Clinical Trial Update: Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial evaluating vardenafil as an add-on therapy for patients with pulmonary arterial hypertension who are treated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Iloprost (iloprost)
• Vardenafil (vardenafil)

Snippet

Sponsor: Rabin Medical Center | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: UNKNOWN